Phibro Animal Health (NASDAQ:PAHC) Trading Down 5.1% - Should You Sell?

Shares of Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) traded down 5.1% during mid-day trading on Tuesday . The stock traded as low as $17.11 and last traded at $17.00. 57,908 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 189,139 shares. The stock had previously closed at $17.91.

Wall Street Analyst Weigh In

A number of brokerages recently commented on PAHC. Barclays increased their price target on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Morgan Stanley set a $20.00 target price on Phibro Animal Health in a research report on Tuesday, April 15th. Finally, StockNews.com lowered shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $19.75.

Phibro Animal Health Stock Performance

The firm has a market capitalization of $700.30 million, a PE ratio of 36.02, a P/E/G ratio of 0.45 and a beta of 0.63. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The business has a 50-day simple moving average of $21.46 and a 200-day simple moving average of $22.29.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.78%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's payout ratio is currently 100.00%.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently modified their holdings of PAHC. Barclays PLC increased its stake in Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after purchasing an additional 29,271 shares during the period. Geode Capital Management LLC increased its stake in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after buying an additional 27,201 shares during the period. SG Americas Securities LLC lifted its holdings in Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after buying an additional 906 shares in the last quarter. Inspire Investing LLC purchased a new stake in Phibro Animal Health in the 4th quarter valued at about $791,000. Finally, Smith Group Asset Management LLC bought a new position in Phibro Animal Health in the 4th quarter worth about $541,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.